TR200003014T2 - Farmasötik maddelerin yavaş salınımı için bir matris olarak işlevsel gruplara sahip olan çapraz-bağlanmış yüksek amiloz nişasta - Google Patents

Farmasötik maddelerin yavaş salınımı için bir matris olarak işlevsel gruplara sahip olan çapraz-bağlanmış yüksek amiloz nişasta

Info

Publication number
TR200003014T2
TR200003014T2 TR2000/03014T TR200003014T TR200003014T2 TR 200003014 T2 TR200003014 T2 TR 200003014T2 TR 2000/03014 T TR2000/03014 T TR 2000/03014T TR 200003014 T TR200003014 T TR 200003014T TR 200003014 T2 TR200003014 T2 TR 200003014T2
Authority
TR
Turkey
Prior art keywords
high amylose
cross
pharmaceuticals
matrix
amylose starch
Prior art date
Application number
TR2000/03014T
Other languages
English (en)
Inventor
Lenaerts Vincent
Chouinard Fran�O�S
A. Mateescu Mircea
Ispas-Szabo Pompilia
Original Assignee
Lenaerts Vincent
Chouinard Fran�O�S
A. Mateescu Mircea
Ispas-Szabo Pompilia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lenaerts Vincent, Chouinard Fran�O�S, A. Mateescu Mircea, Ispas-Szabo Pompilia filed Critical Lenaerts Vincent
Publication of TR200003014T2 publication Critical patent/TR200003014T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut bulus, oral olarak etkin bir farmasötik araci, tercihi bir polisakkaridin veya poliol ve yüksek amiloz nisastanin terapötik bir miktarinin karisimindan olusan bir kati dozaj birimi içeren amilaza karsi dirençli bir kati yavas salinimli oral farmasötik dozaj birimi ile ilgili olup, burada, yüksek amiloz nisastanin çapraz baglamasinin, 100 gr. yüksek amiloz nisasta basina yaklasik olarak 0.1 - 40 gr. çapraz baglama araci ile yerine getirilmesidir. Mevcut bulusun tercih edilen bir kullaniminda, yüksek amiloz nisastanin, esdeger gruplari esdeger olarak baglayan bir islevsel grup-ekleme reaktifi ile degistirilmistir.
TR2000/03014T 1998-02-24 1999-02-24 Farmasötik maddelerin yavaş salınımı için bir matris olarak işlevsel gruplara sahip olan çapraz-bağlanmış yüksek amiloz nişasta TR200003014T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/028,385 US6284273B1 (en) 1998-02-24 1998-02-24 Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds

Publications (1)

Publication Number Publication Date
TR200003014T2 true TR200003014T2 (tr) 2001-02-21

Family

ID=21843160

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03014T TR200003014T2 (tr) 1998-02-24 1999-02-24 Farmasötik maddelerin yavaş salınımı için bir matris olarak işlevsel gruplara sahip olan çapraz-bağlanmış yüksek amiloz nişasta

Country Status (19)

Country Link
US (2) US6284273B1 (tr)
EP (1) EP1059915B1 (tr)
JP (1) JP2002504508A (tr)
KR (1) KR100713702B1 (tr)
CN (1) CN1298297A (tr)
AT (1) ATE277604T1 (tr)
AU (1) AU755069B2 (tr)
BR (1) BR9908187A (tr)
CA (1) CA2321461C (tr)
CZ (1) CZ301010B6 (tr)
DE (1) DE69920669T2 (tr)
HU (1) HU225045B1 (tr)
IL (1) IL137955A (tr)
NO (1) NO329257B1 (tr)
NZ (1) NZ506437A (tr)
PL (1) PL192468B1 (tr)
PT (1) PT1059915E (tr)
TR (1) TR200003014T2 (tr)
WO (1) WO1999043305A1 (tr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100389752C (zh) * 1978-04-21 2008-05-28 莱博法姆公司 控释组合物
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
DE19927688A1 (de) * 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
EP1387885A1 (en) * 2001-05-01 2004-02-11 Universite Du Quebec A Montreal Tridimensional biocompatible support structure for bioartificial organs and uses thereof
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
MXPA05004410A (es) * 2002-10-25 2005-11-23 Labopharm Inc Composiciones de liberacion controlada.
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
EP1713498A4 (en) * 2004-02-09 2009-07-15 Transfert Plus Sec POLYMERIC MATERIAL CONTAINING COMPOSITION AND ITS USES
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
JP5269595B2 (ja) 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
CN101309709A (zh) * 2005-09-21 2008-11-19 苏尔莫迪克斯公司 包含天然生物可降解的多糖的涂层和物品
WO2007035865A1 (en) * 2005-09-21 2007-03-29 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
US20090074829A1 (en) * 2006-03-14 2009-03-19 Masao Tanihara Novel Heparin Alternative Material and Method for Producing the Same
CA2590821A1 (en) * 2007-06-07 2008-12-07 Universite De Montreal High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same
EP2203166B1 (en) * 2007-10-16 2015-05-06 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
CN101161684B (zh) * 2007-11-23 2010-05-19 华南理工大学 交联羧甲基淀粉的红外线合成方法
JP5651818B2 (ja) 2007-12-17 2015-01-14 パラディン ラブス インコーポレーテッド 誤用を防止するための放出制御製剤
KR20100099307A (ko) * 2007-12-21 2010-09-10 아크조 노벨 엔.브이. 열경화성 폴리머
US8936811B2 (en) 2008-05-07 2015-01-20 Surmodics, Inc. Device coated with glycogen particles comprising nucleic acid complexes
WO2010028489A1 (en) * 2008-09-15 2010-03-18 Labopharm Inc. Starch-based microparticles for the release of agents disposed therein
AU2009327312A1 (en) 2008-12-16 2011-08-04 Labopharm Europe Limited Misuse preventative, controlled release formulation
WO2012003968A1 (en) 2010-07-06 2012-01-12 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
CA2865917C (en) * 2011-03-01 2020-09-29 4413261 Canada Inc. (Spencer Canada) Two speed monolithic system for controlled release of drugs
JP6605508B2 (ja) * 2014-02-27 2019-11-13 ビー‐オーガニック フィルムス コーポレイション 一重らせんｖ構造を有する官能化デンプン中に含まれる生物活性剤
SG11201704537QA (en) 2014-12-19 2017-07-28 Baxter Int Flowable hemostatic composition
CN104784738B (zh) * 2015-04-03 2016-12-07 四川大学 一种天然缓释多效医用海绵
CN106279453B (zh) 2015-05-28 2019-12-10 易媛 交联的高分子化合物及其制备方法、水凝胶、水基压裂液和用途
CN105536058A (zh) * 2016-01-22 2016-05-04 青岛中腾生物技术有限公司 一种医用淀粉海绵及其制备方法和用途
GB2567493B (en) * 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
CN111072791A (zh) * 2019-12-27 2020-04-28 河南新孚望新材料科技有限公司 一种包膜剂用高直链淀粉的制备方法
JP7125216B1 (ja) 2021-03-31 2022-08-24 長瀬産業株式会社 水溶性ポリマーの製造方法、および吸水性樹脂の製造方法
JP7348412B2 (ja) * 2021-03-31 2023-09-20 長瀬産業株式会社 水溶性ポリマーの製造方法、および吸水性樹脂の製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
JPH0791240B2 (ja) * 1987-04-01 1995-10-04 株式会社日本触媒 ２−ハロエチルアミンハロゲン化水素酸塩の製造方法
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
JPH06271704A (ja) * 1993-03-22 1994-09-27 Asahi Chem Ind Co Ltd 水性易燃性組成物
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
CA2187633A1 (en) * 1994-04-11 1995-10-19 Douglas R. Chambers Superabsorbent polymers and products therefrom
US5830884A (en) * 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
US5593503A (en) * 1995-06-07 1997-01-14 National Starch And Chemical Investment Holding Corporation Process for producing amylase resistant granular starch
US5667637A (en) * 1995-11-03 1997-09-16 Weyerhaeuser Company Paper and paper-like products including water insoluble fibrous carboxyalkyl cellulose
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds

Also Published As

Publication number Publication date
CZ20003097A3 (en) 2001-06-13
HUP0100818A2 (hu) 2001-08-28
BR9908187A (pt) 2000-10-31
CA2321461C (en) 2008-04-29
NO20004208D0 (no) 2000-08-23
HUP0100818A3 (en) 2001-12-28
US6284273B1 (en) 2001-09-04
KR100713702B1 (ko) 2007-05-02
EP1059915A1 (en) 2000-12-20
US6419957B1 (en) 2002-07-16
JP2002504508A (ja) 2002-02-12
NO20004208L (no) 2000-08-23
WO1999043305A1 (en) 1999-09-02
KR20010034531A (ko) 2001-04-25
AU755069B2 (en) 2002-12-05
PL342596A1 (en) 2001-06-18
HU225045B1 (en) 2006-05-29
IL137955A0 (en) 2001-10-31
CA2321461A1 (en) 1999-09-02
NZ506437A (en) 2003-03-28
ATE277604T1 (de) 2004-10-15
EP1059915B1 (en) 2004-09-29
AU3242099A (en) 1999-09-15
PL192468B1 (pl) 2006-10-31
PT1059915E (pt) 2005-02-28
DE69920669T2 (de) 2005-11-03
CN1298297A (zh) 2001-06-06
DE69920669D1 (de) 2004-11-04
CZ301010B6 (cs) 2009-10-14
NO329257B1 (no) 2010-09-20
IL137955A (en) 2005-12-18

Similar Documents

Publication Publication Date Title
TR200003014T2 (tr) Farmasötik maddelerin yavaş salınımı için bir matris olarak işlevsel gruplara sahip olan çapraz-bağlanmış yüksek amiloz nişasta
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
TR199800743A2 (tr) Ispençiyari uygulamaya mahsus devamli salivermeli polimer karisim matrisi.
TR199801680T2 (tr) Beta-laktam antibiyotik içeren tabletler ve üretim yöntemi.
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
ME00482B (me) Čvrste farmaceutske kompozicije koje sadrže pregabalin sredstvo za formiranje matriksa i sredstvo za bubrenje
BRPI0512410A (pt) compostos de amido e seu uso como produtos farmacêuticos
BRPI0518022A (pt) compostos de lactam e seu uso como produtos farmacêuticos
DK1578406T3 (da) Farmaceutisk sammensætning med modificeret frigivelse
AR012717A1 (es) Trihidrato de la sal de magnesio de s-omeprazol, proceso para su preparacion, composicion farmaceutica, y uso de dicho trihidrato para la fabricacion de medicamentos.
ATE206432T1 (de) A3 -adenosin -rezeptor agonisten
HUP0101512A2 (hu) Adhéziós mikrogyöngy hatóanyag-adagoló készítmény, eljárás az előállítására és a készítményt tartalmazó eszköz
TR200200313T2 (tr) Hızla çözünen dozaj formu ve bunun yapım prosesi.
TR200102002T2 (tr) Ağız yoluyla verildikten sonra gliklazid'in uzun sürede salınmasını sağlayan matris tablet.
BR0017030B8 (pt) derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
WO2003095437A8 (fr) Derives d'aralkyl formyl-alkyl piperazine et leurs utilisations en tant qu'agent protecteur du nerf cerebral
TR200400187T2 (tr) Yeni oral formülasyon.
BR0012610A (pt) Novo derivado de difenilpiperidina
TR200201071T2 (tr) Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
ID17321A (id) Orto-benzoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya.
CY1115009T1 (el) Στερεες απο του στοματος φαρμακευτικες συνθεσεις για δοσολογηση μιας φορας ημερησιως που περιεχουν πρεγκαμπαλινη, παραγοντα σχηματισμου μητρας και παραγοντα διογκωσης
BRPI0315657B8 (pt) formulação de dosagem sólida, comprimido para liberação controlada, método de fabricar uma medicação de liberação controlada, composição farmacêutica e uso de uma composição
SE9502265D0 (sv) Användning av substituerade pentos- eller hexosderivat, som fysiologiskt aktiva substanser samt komposition innehållande dessa
BR1100985A (pt) Composição farmacêutica para liberação estendida de um derivado de eritromicina no ambiente gastrointestinal.